Jagsonpal Pharmaceuticals Limited Stock

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). It operates through the pharmaceuticals business as its segment. The Company operates across therapeutic areas including gynecology, orthopedics, and dermatology. It offers a comprehensive portfolio addressing women’s health, hormonal balance, and pregnancy care. Its brands include Maintane Injections and Tablets, Endoreg, Relufem, Doxypal DR-L, Queezy-ER, Lycored range, Divatrone/SR, FeProtien, Finease, Cycloreg & Fibristone. It is also focused on anti-inflammatory and pain management therapies, with brands such as Indocap, Indocap SR/ P/ EMR, Eclonac P/SP and Metade. Its dermatology portfolio addresses a range of skincare needs, with brands including the Eukroma range, Pru, Sunkroma, Lulyera XL, and the KTC group.